chf

Mainstay Medical Applies for CE Mark for ReActiv8®

on 02/11/2015 11:38
A key step towards European commercialisation of innovative treatment of chronic low back pain
Read more

Nexstim Plc supports 7th International Symposium on Navigated Brain Stimulation in Neurosurgery

on 08/10/2015 15:07

Euroscreen raises € 16 million in Equity Investments

on 02/10/2015 10:52

Data Safety Monitoring Board recommends continuation of Nexstim Plc’s Phase III Stroke Therapy Trial

on 26/09/2015 17:13
Interim data analysis by an independent Data Safety Monitoring Board shows that safety criteria are met and trial should continue without any modifications
Read more

Positive Results for Mainstay Medical’s Clinical Trial of ReActiv8®

on 31/08/2015 11:34
Clinically important, statistically significant, and lasting improvement in pain, disability, and quality of life for people with Chronic Low Back Pain and limited treatment options.
Read more